Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents

Trial Profile

Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Jan 2017

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections; Rheumatoid arthritis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 15 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 04 Nov 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Dec 2015 as per Clinicaltrials.gov.
    • 21 Sep 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top